Xanthan gum therapeutic compositions

Details Xanthan gum therapeutic compositions Xanthan gum therapeutic compositions

1977-01-31

1979-01-23

Meyers, Albert T.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

424258, 424273R, 424300, 424361, A61K 3147, A61K 3166, A61K 3127, A61K 31415

Patent

active

041361776

ABSTRACT:
Ophthalmic compositions are disclosed comprising an ophthalmic drug and xanthan gum.

REFERENCES:
patent: 2703777 (1955-03-01), Feinstein et al.
patent: 3416530 (1968-12-01), Ness
patent: 3640741 (1972-02-01), Etes
patent: 3659026 (1972-04-01), Schuppner
patent: 3700451 (1972-10-01), Sullivan
patent: 3870791 (1975-03-01), Haddad et al.
patent: 3900569 (1975-08-01), Monti
patent: 3944427 (1976-03-01), Sullivan
patent: 4012333 (1977-03-01), Towle
"The Pharmacopeia of the U.S.A." 18th Revision 9/1/70, pp. 220-221 and 505-506.
J. of Pharm. Sci. 63(5) 721-724 (1974), Lee et al., "Corneal Absorption of Ophthalmic Drugs".

Affiliated with

Also associated with

Rating

Xanthan gum therapeutic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Xanthan gum therapeutic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthan gum therapeutic compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2273380